These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 23452678)

  • 41. Substance abuse in patients with attention-deficit hyperactivity disorder : therapeutic implications.
    Schubiner H
    CNS Drugs; 2005; 19(8):643-55. PubMed ID: 16097847
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Attention-deficit hyperactivity disorders in adolescence.
    Wender EH
    J Dev Behav Pediatr; 1995 Jun; 16(3):192-5. PubMed ID: 7560123
    [No Abstract]   [Full Text] [Related]  

  • 43. Childhood stimulant treatment and risk for later substance abuse.
    Fischer M; Barkley RA
    J Clin Psychiatry; 2003; 64 Suppl 11():19-23. PubMed ID: 14529326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Central nervous system stimulants and their potential risk of abuse in hyperkinetic disorders].
    Aanonsen NO
    Tidsskr Nor Laegeforen; 1999 Nov; 119(27):4040-2. PubMed ID: 10613094
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Practice parameter for the use of stimulant medications.
    Ravenel SD
    J Am Acad Child Adolesc Psychiatry; 2002 Oct; 41(10):1146-7; author reply 1147. PubMed ID: 12364835
    [No Abstract]   [Full Text] [Related]  

  • 46. Treatment of attention-deficit-hyperactivity disorder.
    Elia J; Ambrosini PJ; Rapoport JL
    N Engl J Med; 1999 Mar; 340(10):780-8. PubMed ID: 10072414
    [No Abstract]   [Full Text] [Related]  

  • 47. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
    Janols LO; Liliemark J; Klintberg K; von Knorring AL
    Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects.
    Leonard BE; McCartan D; White J; King DJ
    Hum Psychopharmacol; 2004 Apr; 19(3):151-80. PubMed ID: 15079851
    [No Abstract]   [Full Text] [Related]  

  • 49. Comparing the abuse potential of methylphenidate versus other stimulants: a review of available evidence and relevance to the ADHD patient.
    Kollins SH
    J Clin Psychiatry; 2003; 64 Suppl 11():14-8. PubMed ID: 14529325
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Stimulant treatment for ADHD may not increase risk of substance abuse.
    Harv Ment Health Lett; 2008 Jun; 24(12):7. PubMed ID: 18946888
    [No Abstract]   [Full Text] [Related]  

  • 51. Attention deficit hyperactivity disorder: part III.
    Ryan-Krause P
    J Pediatr Health Care; 2011; 25(1):50-6. PubMed ID: 21147408
    [No Abstract]   [Full Text] [Related]  

  • 52. The diagnosis and treatment of attention deficit-hyperactivity disorder in children and adolescents with cystic fibrosis: a retrospective study.
    Georgiopoulos AM; Hua LL
    Psychosomatics; 2011; 52(2):160-6. PubMed ID: 21397109
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An unlikely vice: Ritalin.
    Vishio J
    Adv Nurse Pract; 2001 Feb; 9(2):60. PubMed ID: 12416056
    [No Abstract]   [Full Text] [Related]  

  • 54. Attention deficit hyperactivity disorder in children.
    Ramchandani P; Joughin C; Zwi M
    Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
    [No Abstract]   [Full Text] [Related]  

  • 55. A symposium on Attention Deficit Hyperactivity Disorder (ADHD). 'Kid in the corner'.
    Hazell P
    Aust N Z J Psychiatry; 2002 Aug; 36(4):475-7. PubMed ID: 12169141
    [No Abstract]   [Full Text] [Related]  

  • 56. Attention Deficit Disorder. A guide for the practitioner.
    Karniski W
    J Fla Med Assoc; 1983 Apr; 70(4):257-61. PubMed ID: 6133906
    [No Abstract]   [Full Text] [Related]  

  • 57. Universal precautions to reduce stimulant misuse in treating adult ADHD.
    Modesto-Lowe V; Chaplin M; Sinha S; Woodard K
    Cleve Clin J Med; 2015 Aug; 82(8):506-12. PubMed ID: 26270429
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cardiovascular Safety of Stimulants in Children with Attention-Deficit/Hyperactivity Disorder.
    Poulton A; Zehetner A
    J Child Adolesc Psychopharmacol; 2015 Dec; 25(10):824. PubMed ID: 25325905
    [No Abstract]   [Full Text] [Related]  

  • 59. Cardiovascular safety of stimulants in children with attention-deficit/hyperactivity disorder.
    Kiely B; Adesman A
    J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):180. PubMed ID: 25325161
    [No Abstract]   [Full Text] [Related]  

  • 60. The diversion and misuse of pharmaceutical stimulants: what do we know and why should we care?
    Kaye S; Darke S
    Addiction; 2012 Mar; 107(3):467-77. PubMed ID: 22313101
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.